Candriam S.C.A. Purchases 17,401 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Candriam S.C.A. lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 247,627 shares of the medical equipment provider’s stock after purchasing an additional 17,401 shares during the quarter. Intuitive Surgical comprises approximately 0.7% of Candriam S.C.A.’s portfolio, making the stock its 27th largest holding. Candriam S.C.A. owned approximately 0.07% of Intuitive Surgical worth $129,251,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Massachusetts Financial Services Co. MA purchased a new stake in Intuitive Surgical during the third quarter valued at about $558,807,000. Proficio Capital Partners LLC boosted its position in Intuitive Surgical by 89,098.8% during the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after buying an additional 948,902 shares during the period. FMR LLC boosted its position in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the period. Raymond James Financial Inc. purchased a new stake in Intuitive Surgical during the fourth quarter valued at about $313,769,000. Finally, Wilmington Savings Fund Society FSB boosted its position in Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after buying an additional 552,058 shares during the period. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the sale, the executive vice president now owns 353 shares of the company’s stock, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $566.94, for a total transaction of $106,584.72. Following the completion of the sale, the chief financial officer now directly owns 7,162 shares of the company’s stock, valued at approximately $4,060,424.28. This trade represents a 2.56 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 12,598 shares of company stock valued at $7,223,467. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Up 1.8 %

NASDAQ:ISRG opened at $568.02 on Thursday. The company’s 50 day moving average price is $571.70 and its 200-day moving average price is $530.90. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The stock has a market cap of $202.32 billion, a price-to-earnings ratio of 88.61, a PEG ratio of 5.85 and a beta of 1.43.

Analyst Ratings Changes

ISRG has been the subject of several analyst reports. BTIG Research upped their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Evercore ISI upped their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, Bernstein Bank upped their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.